Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · IEX Real-Time Price · USD
7.04
+0.45 (6.83%)
At close: Mar 27, 2024, 4:00 PM
6.63
-0.41 (-5.82%)
Pre-market: Mar 28, 2024, 5:47 AM EDT

Monte Rosa Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for GLUE stock have an average target of 11, which predicts an increase of 56.25% from the current stock price of 7.04.

Analyst Consensus: Buy
Target Low Average Median High
Price $11 $11 $11 $11
Change +56.25% +56.25% +56.25% +56.25%
* Price targets were last updated on Feb 15, 2024.

Analyst Ratings

The average analyst rating for GLUE stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 000000
Buy 222222
Hold 111111
Sell 000000
Strong Sell 000000
Total 333333

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wedbush
Wedbush
Buy
Initiates
$11
Buy Initiates $11 +56.25% Feb 15, 2024
JP Morgan
JP Morgan
Buy
Maintains
$31$11
Buy Maintains $31$11 +56.25% Oct 19, 2023
Credit Suisse
Credit Suisse
Hold
Reiterates
$11
Hold Reiterates $11 +56.25% Aug 11, 2023
Credit Suisse
Credit Suisse
Hold
Reiterates
$11
Hold Reiterates $11 +56.25% May 12, 2023
Credit Suisse
Credit Suisse
Hold
Maintains
$12$11
Hold Maintains $12$11 +56.25% Mar 17, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
4.61M
Revenue Next Year
6.05M
from 4.61M
Increased by 31.17%
EPS This Year
-2.74
from -2.63
EPS Next Year
-2.42
from -2.74
Year 2019202020212022202320242025202620272028
Revenue
-----4.61M6.05M19.89M126.99M281.93M
Revenue Growth
------31.17%228.65%538.46%122.01%
EPS
-1.55-23.65-2.96-2.30-2.63-2.74-2.42-2.57-1.370.26
EPS Growth
----------
No. Analysts -----109765
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 17.5M 17.5M 81.9M 368.6M 671.0M
Avg 4.6M 6.1M 19.9M 127.0M 281.9M
Low n/a n/a n/a n/a 39.4M

Revenue Growth

Revenue Growth 20242025202620272028
High -
279.3%
1,253.3%
1,752.9%
428.3%
Avg -
31.2%
228.7%
538.5%
122.0%
Low - - - -
-69.0%

EPS Forecast

EPS 20242025202620272028
High -2.48 -1.94 -1.76 1.49 4.75
Avg -2.74 -2.42 -2.57 -1.37 0.26
Low -3.19 -2.87 -3.34 -2.79 -2.17

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.